Companies / Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc.
Insider pressure
open-market buys vs sells · 90 days
Net selling−$2.95M
Last 30 days: $0 net · 0 buying / 0 selling
Financials
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | Regan Andrew CEO | Sell Open-market sale | Common Stock | $3.25M | -10.2M -85.83% | 1,691,727 215.05% of shares | medium |
| Jun 18, 2026 | Taylor Mark Andrew 10% owner | Sell Open-market sale | Common Stock | $2.11M | -1.5M -100.00% | 0 0.00% of shares | medium |
| Jun 18, 2026 | Taylor Mark Andrew 10% owner | Sell Open-market sale | Common Stock | $829.1K | -593K -100.00% | 0 0.00% of shares | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CDT | common | 20678X106 |
| CDT | common | 20678X205 |
| CDT | common | 20678X304 |
| CDT | common | 20678X403 |
| CDT | common | 20678X502 |